ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IDD Innate Pharma

1.602
-0.09 (-5.32%)
16:29:06 - Realtime Data
Share Name Share Symbol Market Type
Innate Pharma TG:IDD Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.09 -5.32% 1.602 1.576 1.614 1.644 1.602 1.64 205 16:29:06

Result of AGM and EGM

04/09/2003 10:56am

UK Regulatory


RNS Number:3836P
ID Data PLC
04 September 2003


Press Release                             4 September 2003


                                 ID Data plc
                            Result of AGM and EGM


ID Data, the card solutions and intellectual property company ("the Company"),
is pleased to announce that all resolutions proposed at the Company's Annual
General Meeting and Extraordinary General Meeting held today were duly passed.


Accordingly, Shareholders approved the Loan Note Instrument dated 1 August 2003
allowing the Company to issue up to #4 million secured convertible loan notes
2008.  A further update will be provided in due course.


In his statement to Shareholders, the Chairman Mike Blackburn said: "The Company
has made a positive start to the financial year and we remain optimistic about
prospects for the business."


For further information, please contact:

ID Data plc

Peter Cox                                             Tel: +44 (0) 1536 207000
enquiries@id-data.co.uk


Media Enquiries:

Bankside

Peter Curtain / Heather Salmond                       Tel: +44 (0) 20 7444 4140
heather.salmond@bankside.com

Notes to Editors:


ID Data plc


ID Data plc ("ID Data") is the world's seventh-largest supplier of
secure-transaction systems and smart-card services to the international
telephony, banking, retail, and secure-access sectors.  The Company's strategy,
to move from commodity products to value-added services and solutions, has
created a solid platform on which to build further growth.  The Company's
clients include Vodafone, Nectar, Tesco, the Automobile Association, Exxon Mobil
and, in Poland, the Premium Club loyalty card scheme.  ID Data has formed
agreements with major global corporations to facilitate rapid market development
including partnerships with Toshiba and Toppan.  The Company has delivered in
excess of 10 million chip cards to the banking market in the UK.  The Company
was founded in 1988 and was listed on AIM in October 2000.

www.id-data.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCNKQKPCBKKQCK

1 Year Innate Pharma Chart

1 Year Innate Pharma Chart

1 Month Innate Pharma Chart

1 Month Innate Pharma Chart

Your Recent History

Delayed Upgrade Clock